Cedara (NASDAQ:CDSW)
Historical Stock Chart
From Jun 2019 to Jun 2024
Cedara Receives 2004 Fastest Growing Company of the Year Award
from Frost and Sullivan
FLORIDA, Nov. 10 /PRNewswire-FirstCall/ -- Cedara Software Corp.
(NASDAQ:CDSW/TSX:CDE) a leading independent developer of medical software
technologies for the global healthcare market, announced that Frost and
Sullivan, America's foremost market research and consulting firm, has voted
Cedara the recipient of its 2004 Fastest Growing Company of the Year Award.
Frost and Sullivan formally presented the prestigious award to Cedara last
night, at its 2004 Global Excellence in the Healthcare and Life Sciences Awards
Banquet in Florida.
Frost and Sullivan is a leading market consulting and research organization
that monitors new technologies, tracks changes in distribution channels,
forecasts market trends, and performs strategic analysis of competitors in the
healthcare industry.
Each year Frost and Sullivan recognizes outstanding industry achievements by
presenting Frost & Sullivan Awards to top companies in regional and global
markets. Its industry experts recognize the diligence and innovation required
to implement a successful business plan and excel in the increasingly
competitive global marketplace.
"Cedara is honored to be the recipient of the highly esteemed Frost and
Sullivan Fastest Growing Company of the Year Award, and to be recognized by an
industry analyst of such exceptional caliber," said Abe Schwartz, Cedara
President and CEO.
"We have been following Cedara for many years and have been quite excited by
their recent performance within the healthcare industry. They have grown from
being a small niche competitor to one that offers a breadth of valuable medical
software solutions to a diverse group of global healthcare clients. Their focus
on cutting edge technologies in conjunction with flexible solutions has allowed
them to make tremendous strides within the industry," says Monali Patel, Frost
and Sullivan Research Manager, Medical Imaging.
"Having our business model validated by a top industry analyst is a powerful
endorsement of how successful Cedara is with its strategy of offering
diversified, end-to-end products and services," said Jacques Cornet, Cedara
Vice President of Marketing and Operations.
About Cedara Software:
Cedara Software Corp. is a leading independent provider of medical technologies
for many of the world's leading medical device and healthcare information
technology companies. Cedara software is deployed in hospitals and clinics
worldwide - approximately 28,000 medical imaging systems and 6,400 Picture
Archiving and Communications System (PACS) workstations have been licensed to
date. Cedara is enabling the future of the healthcare industry with new
innovative approaches to workflow, data and image management, integration, the
web, software components and professional services. The Company's medical
imaging solutions are used in all aspects of clinical workflow including the
capture of patient digital images; the sharing and archiving of images;
sophisticated tools to analyze and manipulate images; and even the use of
imaging in surgery. Cedara is unique in that it has expertise and technologies
that span all the major digital imaging modalities including angiography,
computed tomography (CT), echo-cardiology, digital X-ray, fluoroscopy,
mammography, magnetic resonance imaging (MRI), nuclear medicine, positron
emission tomography (PET) and ultrasound.
Certain statements contained in this news release are forward-looking within
the meaning of securities laws and are based on current expectations that are
subject to a number of assumptions, uncertainties and risks, and there are
actual results may differ materially from what is currently expected. These
assumptions, uncertainties and risks include, but are not limited to: the
management of the growth of the Company, dependence on key personnel of the
Company, competitive pressures (including price competition), changes in market
activity, risks associated with international operations, the development of
new products and services, the enhancement of existing products and services,
the introduction of competing products having technological and/or other
advantages, the dependence on key customers, regulatory changes to the health
care industry, seasonality, economic and political conditions and adequate
protection of the proprietary interests of the Company. Further information
about these risks and uncertainties can be found in the continuous disclosure
documents filed from time to time by Cedara with the securities regulatory
authorities, which documents are available at http://www.sedar.com/.
All trademarks appearing in this release are the property of
Cedara Software Corp.
DATASOURCE: Cedara Software Corp.
CONTACT: For more information about Cedara and its products and
services, visit the Cedara website at http://www.cedara.com/ or contact:
Michelle
Pommells, Cedara Software Corp., (905) 672-2100 ext. 2356, Email:
.; For investor-related inquiries, contact: Brian Pedlar,
Chief Financial Officer, (905) 672-2100 ext. 2015, Email:
;
To request a free copy of this organization's annual report, please go to
http://www.newswire.ca/ and click on reports@cnw.